Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
IRTC · against 254 other Healthcare companies of similar size
Ranked #175 of 255 · scores higher than 31% of peers
Bars: peers in each 10-point band of the profitability score20 peers with a profitability score of 40–49, including IRTC · Click a bar to see the companies
A mix: stronger return on invested capital, but weaker operating margin than most Healthcare peers.
| Metric | IRTC | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Return on invested capitalHigher is better · 246 reported | 16.1% | 8.4% | 74% | 33% | |
| Operating marginHigher is better · 233 reported | -7.1% | 11.0% | 17% | 33% | |
| Return on assetsHigher is better · 241 reported | 0.6% | 3.4% | 34% | 33% | |
| Return on equityHigher is better · 237 reported | -9.6% | 7.5% | 27% | Context only | |
| Gross marginHigher is better · 262 reported | 71.5% | 48.0% | 82% | Context only |
| Rank | Company | Market cap | Profitability | Overall |
|---|---|---|---|---|
| 1 | 3.1B EUR (≈$3.4B) | 100 | 100 | |
| 1 | 321.5B INR (≈$3.9B) | 100 | 70 | |
| 1 | 174.8B INR (≈$2.1B) | 100 | 73 | |
| 4 | 51.3B ZAR (≈$2.8B) | 99 | 73 | |
| 4 | 3.8B USD | 99 | 71 | |
| 171 | 7.7B USD | 47 | 37 | |
| 171 | 5.1B USD | 47 | 52 | |
| 171 | 2.2B USD | 47 | 37 | |
| 175 | 17.8B CNY (≈$2.5B) | 46 | 39 | |
| 175 | 4.2B USD | 46 | 41 | |
| 177 | 388.2B JPY (≈$2.6B) | 44 | 62 | |
| 177 | 3.0B CHF (≈$3.5B) | 44 | 33 | |
| 179 | 428.3B JPY (≈$2.9B) | 43 | 59 | |
| 180 | 3.1B USD | 42 | 53 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score